The Power of Asymmetry: Architecture and Assembly of the Gram-Negative Outer Membrane Lipid Bilayer

Annual Review of Microbiology

Volumn 70, Issue , 2016, Pages 255-278

  Henderson, Jeremy C ^a   Zimmerman, Shawn M ^b   Crofts, Alexander A ^a   Boll, Joseph M ^a   Kuhns, Lisa G ^b   Herrera, Carmen M ^b   Trent, M Stephen ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Commensals; Lipid A; Lipopolysaccharide; LPS; Outer membrane vesicles; Phospholipids; Vaccines

Indexed keywords

ADJUVANT; ENDOTOXIN; GLYCEROPHOSPHOLIPID; GLYCOCONJUGATE; LIPID; LIPID A; LIPOPOLYSACCHARIDE; LIPID BILAYER;

BACTERIAL CELL; CELL SURFACE; COMMENSAL; DETOXIFICATION; GRAM NEGATIVE BACTERIUM; HUMAN; LIPID BILAYER; LIPID TRANSPORT; MEMBRANE VESICLE; NONHUMAN; OUTER MEMBRANE; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; REVIEW; CELL MEMBRANE; CHEMISTRY; GENETICS; METABOLISM;

CELL MEMBRANE; GRAM-NEGATIVE BACTERIA; LIPID BILAYERS;

EID: 84986575663     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-102215-095308     Document Type: Review

References (153)

1. Acevedo R, Fernández S, Zayas C, Acosta A, Sarmiento ME, et al. 2014. Bacterial outer membrane vesicles and vaccine applications. Front. Immunol. 5:121
2. Anderson MS, Robertson AD, Macher I, Raetz CR. 1988. Biosynthesis of lipid A in Escherichia coli: Identification of UDP-3-O-[(R)-3-hydroxymyristoyl]-a-D-glucosamine as a precursor of UDP-N2,O3-bis[(R)-3-hydroxymyristoyl]-a-D-glucosamine. Biochemistry 27(6):1908-17
3. Asensio CJA, Gaillard ME, Moreno G, Bottero D, Zurita E, et al. 2011. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate. Vaccine 29(8):1649-56
4. Bainbridge BW, Karimi-Naser L, Reife R, Blethen F, Ernst RK, Darveau RP. 2008. Acyl chain specificity of the acyltransferases LpxA and LpxD and substrate availability contribute to lipid A fatty acid heterogeneity in Porphyromonas gingivalis. J. Bacteriol. 190(13):4549-58
5. Barb AW, McClerren AL, Snehelatha K, Reynolds CM, Zhou P, Raetz CRH. 2007. Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli. Biochemistry 46(12):3793-802
6. Barb AW, Zhou P. 2008. Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis. Curr. Pharm. Biotechnol. 9(1):9-15
7. Bartling CM, Raetz CRH. 2009. Crystal structure and acyl chain selectivity of Escherichia coli LpxD, the N-acyltransferase of lipid A biosynthesis. Biochemistry 48(36):8672-83
8. Bayer ME. 1991. Zones ofmembrane adhesion in the cryofixed envelope of Escherichia coli. J. Struct. Biol. 107(3):268-80
9. Birck MR, Holler TP, Woodard RW. 2000. Identification of a slow tight-binding inhibitor of 3-deoxy-D-manno-octulosonic acid 8-phosphate synthase. J. Am. Chem. Soc. 122(38):9334-35
10. Bishop RE. 2008. Structural biology of membrane-intrinsic β-barrel enzymes: sentinels of the bacterial outer membrane. Biochim. Biophys. Acta Biomembr. 1778(9):1881-96
11. Bishop RE, Gibbons HS, Guina T, Trent MS, Miller SI, Raetz CR. 2000. Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria. EMBO J. 19(19):5071-80
12. Bogdanov M, Xie J,Heacock P, DowhanW.2008. To flip or not to flip: Lipid-protein charge interactions are a determinant of final membrane protein topology. J. Cell Biol. 182(5):925-35
13. Bohin JP, Kennedy EP. 1984. Regulation of the synthesis of membrane-derived oligosaccharides in Escherichia coli: assay of phosphoglycerol transferase I in vivo. J. Biol. Chem. 259(13):8388-93
14. BosMP, Tefsen B,Geurtsen J,Tommassen J. 2004. Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. PNAS 101(25):9417-22
15. Braun M, Silhavy TJ. 2002. Imp/OstA is required for cell envelope biogenesis in Escherichia coli. Mol. Microbiol. 45(5):1289-302
16. Braun V, Bosch V. 1972. Sequence of the murein-lipoprotein and the attachment site of the lipid. Eur. J. Biochem. FEBS. 28(1):51-69
17. Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, et al. 2012. Potent inhibitors of LpxC for the treatment of gram-negative infections. J. Med. Chem. 55(2):914-23
18. Buetow L, Smith TK, Dawson A, Fyffe S, Hunter WN. 2007. Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis. PNAS 104(11):4321-26
19. Carpenter CD, Cooley BJ, Needham BD, Fisher CR, Trent MS, et al. 2014. The Vps/VacJ ABC transporter is required for intercellular spread of Shigella flexneri. Infect. Immun. 82(2):660-69
20. Castuma CE, Crooke E, Kornberg A. 1993. Fluid membranes with acidic domains activate DnaA, the initiator protein of replication in Escherichia coli. J. Biol. Chem. 268(33):24665-68
21. Chng S-S, Gronenberg LS, Kahne D. 2010. Proteins required for lipopolysaccharide assembly in Escherichia coli form a transenvelope complex. Biochemistry 49(22):4565-67
22. Chong Z-S, Woo W-F, Chng S-S. 2015. Osmoporin OmpC forms a complex with MlaA to maintain outer membrane lipid asymmetry in Escherichia coli. Mol. Microbiol. 98(6):1133-46
23. Chung HS, Raetz CR. 2011. Dioxygenases in Burkholderia ambifaria and Yersinia pestis that hydroxylate the outer Kdo unit of lipopolysaccharide. PNAS 108:510-15
24. Cipolla L, Polissi A, Airoldi C,Galliani P, Sperandeo P, Nicotra F. 2009. The Kdo biosynthetic pathway towardOMbiogenesis as target in antibacterial drug design and development. Curr. Drug Discov. Technol. 6(1):19-33
25. Claesson A, Jansson AM, Pring BG, Hammond SM, Ekstr öm B. 1987. Design and synthesis of peptide derivatives of a 3-deoxy-D-manno-2-octulosonic acid (KDO) analogue as novel antibacterial agents acting upon lipopolysaccharide biosynthesis. J. Med. Chem. 30(12):2309-13
26. Claesson A, Luthman K, Gustafsson K, Bondesson G. 1987. A 2-deoxy analogue of KDO as the first inhibitor of the enzyme CMP-KDO synthetase. Biochem. Biophys. Res. Commun. 143(3):1063-68
27. Coats SR, Berezow AB, To TT, Jain S, Bainbridge BW, et al. 2011. The lipid A phosphate position determines differential host toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria. Infect. Immun. 79(1):203-10
28. Cowles CE, Li Y, Semmelhack MF, Cristea IM, Silhavy TJ. 2011. The free and bound forms of Lpp occupy distinct subcellular locations in Escherichia coli. Mol. Microbiol. 79(5):1168-81
29. Cullen PA, Haake DA, Adler B. 2004. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol. Rev. 28(3):291-318
30. Cullen TW, Giles DK, Wolf LN, Ecobichon C, Boneca IG, Trent MS. 2011. Helicobacter pylori versus the host: Remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLOS Pathog. 7(12):e1002454
31. Cullen TW, Schofield WB, Barry NA, Putnam EE, Rundell EA, et al. 2015. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science 347(6218):170-75
32. Dalebroux ZD, Edrozo MB, Pfuetzner RA, Ressl S, Kulasekara BR, et al. 2015. Delivery of cardiolipins to the Salmonella outer membrane is necessary for survival within host tissues and virulence. Cell Host Microbe. 17(4):441-51
33. Dalebroux ZD, Matamouros S, Whittington D, Bishop RE, Miller SI. 2014. PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane. PNAS 111(5):1963-68
34. Darveau RP, Chilton PM. 2013. Naturally occurring low biological reactivity lipopolysaccharides as vaccine adjuvants. Expert Rev. Vaccines 12(7):707-9
35. De VrijeT, de Swart RL,DowhanW,Tommassen J, deKruijff B. 1988. Phosphatidylglycerol is involved in protein translocation across Escherichia coli inner membranes. Nature 334(6178):173-75
36. Dekker N. 2000. Outer-membrane phospholipase A: known structure, unknown biological function. Mol. Microbiol. 35(4):711-17
37. Doerrler WT, GibbonsHS, Raetz CRH. 2004. MsbA-dependent translocation of lipids across the inner membrane of Escherichia coli. J. Biol. Chem. 279(43):45102-9
38. Doerrler WT, Reedy MC, Raetz CR. 2001. An Escherichia coli mutant defective in lipid export. J. Biol. Chem. 276(15):11461-64
39. Dong H, Xiang Q, Gu Y, Wang Z, Paterson NG, et al. 2014. Structural basis for outer membrane lipopolysaccharide insertion. Nature 511(7507):52-56
40. Donohue-Rolfe AM, Schaechter M. 1980. Translocation of phospholipids from the inner to the outer membrane of Escherichia coli. PNAS 77(4):1867-71
41. Dowhan W. 2014. Lipids and extracellular materials. Annu. Rev. Biochem. 83(1):45-49
42. Dowhan W, Bogdanov M. 2009. Lipid-dependent membrane protein topogenesis. Annu. Rev. Biochem. 78:515-40
43. Eckford PDW, Sharom FJ. 2008. Functional characterization of Escherichia coli MsbA: interaction with nucleotides and substrates. J. Biol. Chem. 283(19):12840-50
44. Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, et al. 1999. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286(5444):1561-65
45. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, et al. 2006. Outer membrane vesicles from group B Neisseriameningitidis-gna33 mutant: proteomic and immunological comparison with detergentderived outer membrane vesicles. PROTEOMICS 6(6):1856-66
46. Francisco JA, Earhart CF, Georgiou G. 1992. Transport and anchoring of beta-lactamase to the external surface of Escherichia coli. PNAS 89(7):2713-17
47. Frasch CE. 2009. Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges. Vaccine 27(46):6468-70
48. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, et al. 1997. Genomic sequence of a lyme disease spirochaete, Borrelia burgdorferi. Nature 390(6660):580-86
49. Fraser CM, Norris SJ, Weinstock GM, White O, Sutton GG, et al. 1998. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281(5375):375-88
50. Freinkman E, Chng S-S, Kahne D. 2011. The complex that inserts lipopolysaccharide into the bacterial outer membrane forms a two-protein plug-and-barrel. PNAS 108(6):2486-91
51. Freinkman E, Okuda S, Ruiz N, Kahne D. 2012. Regulated assembly of the transenvelope protein complex required for lipopolysaccharide export. Biochemistry 51(24):4800-6
52. Galen JE, Zhao L, Chinchilla M, Wang JY, Pasetti MF, et al. 2004. Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. Infect. Immun. 72(12):7096-106
53. Garçon N. 2010. Preclinical development of AS04. In Vaccine Adjuvants: Methods and Protocols, ed G Davies, pp. 15-27. New York: Humana
54. Garner J, Crooke E. 1996. Membrane regulation of the chromosomal replication activity of E. coli DnaA requires a discrete site on the protein. EMBO J. 15(9):2313-21
55. Gorringe AR, Pajón R. 2012. Bexsero. Hum. Vaccines Immunother. 8(2):174-83
56. Grabowicz M, Yeh J, Silhavy TJ. 2013. Dominant negative lptE mutation that supports a role for LptE as a plug in the LptD barrel. J. Bacteriol. 195(6):1327-34
57. Gronenberg LS, Kahne D. 2010. Development of an activity assay for discovery of inhibitors of lipopolysaccharide transport. J. Am. Chem. Soc. 132(8):2518-19
58. Gruss F, Zähringer F, Jakob RP, Burmann BM, Hiller S, Maier T. 2013. The structural basis of autotransporter translocation by TamA. Nat. Struct. Mol. Biol. 20(11):1318-20
59. Hantke K, Braun V. 1973. Covalent binding of lipid to protein. Eur. J. Biochem. 34(2):284-96
60. Hittle LE, Powell DA, Jones JW, Tofigh M, Goodlett DR, et al. 2015. Site-specific activity of the acyltransferases HtrB1 and HtrB2 in Pseudomonas aeruginosa lipid A biosynthesis. Pathog. Dis. 73(8):ftv053
61. Holst J, Martin D, Arnold R, Huergo CC, Oster P, et al. 2009. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27(Supp. 2):B3-12
62. Ismaili J, Rennesson J, Aksoy E, Vekemans J, Vincart B, et al. 2002. Monophosphoryl lipid A activates both human dendritic cells and T cells. J. Immunol. 168(2):926-32
63. Jackson BJ, Bohin JP, Kennedy EP. 1984. Biosynthesis of membrane-derived oligosaccharides: characterization of mdoB mutants defective in phosphoglycerol transferase I activity. J. Bacteriol. 160(3):976-81
64. Jackson BJ, Kennedy EP. 1983. The biosynthesis of membrane-derived oligosaccharides: a membranebound phosphoglycerol transferase. J. Biol. Chem. 258(4):2394-98
65. Jenkins RJ, Dotson GD. 2012. Dual targeting antibacterial peptide inhibitor of early lipid A biosynthesis. ACS Chem. Biol. 7(7):1170-77
66. Kamio Y, Nikaido H. 1976. Outer membrane of Salmonella typhimurium: Accessibility of phospholipid head groups to phospholipase C and cyanogen bromide activated dextran in the external medium. Biochemistry 15(12):2561-70
67. Kanfer J, Kennedy EP. 1964. Metabolism and function of bacterial lipids: II. Biosynthesis of phospholipids in Escherichia coli. J. Biol. Chem. 239:1720-26
68. Kawahara K, Seydel U, MatsuuraM, Danbara H, Rietschel ET, Zähringer U. 1991. Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis. FEBS Lett. 292(1-2):107-10
69. Kawasaki S, Moriguchi R, Sekiya K, Nakai T, Ono E, et al. 1994. The cell envelope structure of the lipopolysaccharide-lacking gram-negative bacterium Sphingomonas paucimobilis. J. Bacteriol. 176(2):284-90
70. Kellenberger E. 1990. The "Bayer bridges" confronted with results from improved electron microscopy methods. Mol. Microbiol. 4(5):697-705
71. Kesty NC, Kuehn MJ. 2004. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J. Biol. Chem. 279(3):2069-76
72. Kim JH, Lee J, Park J, Gho YS. 2015. Gram-negative and gram-positive bacterial extracellular vesicles. Semin. Cell Dev. Biol. 40:97-104
73. Kulkarni HM, Jagannadham MV. 2014. Biogenesis and multifaceted roles of outer membrane vesicles from gram-negative bacteria. Microbiology 160(Part 10):2109-21
74. Lee C-J, Liang X, Chen X, Zeng D, Joo SH, et al. 2011. Species-specific and inhibitor-dependent conformations of LpxC: implications for antibiotic design. Chem. Biol. 18(1):38-47
75. Lee C-J, Liang X, Gopalaswamy R, Najeeb J, Ark ED, et al. 2014. Structural basis of the promiscuous inhibitor susceptibility of Escherichia coli LpxC. ACS Chem. Biol. 9(1):237-46
76. Lee C-J, Liang X,Wu Q,Najeeb J, Zhao J, et al. 2016. Drug design from the cryptic inhibitor envelope. Nat. Commun. 7:10638
77. Liang X, Lee C-J, Chen X, ChungHS, Zeng D, et al. 2011. Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold. Bioorg. Med. Chem. 19(2):852-60
78. Liang X, Lee C-J, Zhao J, Toone EJ, Zhou P. 2013. Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors. J. Med. Chem. 56(17):6954-66
79. Lill R, Dowhan W, WicknerW. 1990. The ATPase activity of SecA is regulated by acidic phospholipids, SecY, and the leader and mature domains of precursor proteins. Cell 60(2):271-80
80. Lu Y-H, Guan Z, Zhao J, Raetz CRH. 2011. Three phosphatidylglycerol-phosphate phosphatases in the inner membrane of Escherichia coli. J. Biol. Chem. 286(7):5506-18
81. Malinverni JC, Silhavy TJ. 2009. An ABC transport system that maintains lipid asymmetry in the gramnegative outer membrane. PNAS 106(19):8009-14
82. Mansoor UF, Vitharana D, Reddy PA, Daubaras DL, McNicholas P, et al. 2011. Design and synthesis of potent gram-negative specific LpxC inhibitors. Bioorg. Med. Chem. Lett. 21(4):1155-61
83. Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC. 2007. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316(5831):1628-32
84. Matsumoto K. 2001. Dispensable nature of phosphatidylglycerol in Escherichia coli: dual roles of anionic phospholipids. Mol. Microbiol. 39(6):1427-33
85. McClerren AL, Endsley S, Bowman JL, Andersen NH, Guan Z, et al. 2005. A slow, tight-binding inhibitor of the zinc-dependent deacetylaseLpxC of lipid A biosynthesiswith antibiotic activity comparable to ciprofloxacin. Biochemistry 44(50):16574-83
86. Miller KJ, Kennedy EP. 1987. Transfer of phosphoethanolamine residues from phosphatidylethanolamine to the membrane-derived oligosaccharides of Escherichia coli. J. Bacteriol. 169(2):682-86
87. Moffatt JH, Harper M, Harrison P, Hale JDF, Vinogradov E, et al. 2010. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54(12):4971-77
88. Nakayama H, Kurokawa K, Lee BL. 2012. Lipoproteins in bacteria: Structures and biosynthetic pathways. FEBS J. 279(23):4247-68
89. Narita S, Tokuda H. 2009. Biochemical characterization of an abc transporter lptbfgc complex required for the outer membrane sorting of lipopolysaccharides. FEBS Lett. 583(13):2160-64
90. Nayar AS, Dougherty TJ, Ferguson KE, Granger BA, McWilliams L, et al. 2015. Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay. J. Bacteriol. 197(10):1726-34
91. Needham BD, Carroll SM, Giles DK, Georgiou G, Whiteley M, Trent MS. 2013. Modulating the innate immune response by combinatorial engineering of endotoxin. PNAS 110(4):1464-69
92. Needham BD, Trent MS. 2013. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 11(7):467-81
93. Nguyen BD, Cunningham D, Liang X, Chen X, Toone EJ, et al. 2011. Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis. PNAS 108(25):10284-89
94. Noinaj N, Kuszak AJ, Gumbart JC, Lukacik P, ChangH, et al. 2013. Structural insight into the biogenesis of β-barrel membrane proteins. Nature 501(7467):385-90
95. Okemoto K, Kawasaki K, Hanada K, Miura M, Nishijima M. 2006. A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1β or activation of caspase-1. J. Immunol. 176(2):1203-8
96. Okuda S, Freinkman E, Kahne D. 2012. Cytoplasmic ATP hydrolysis powers transport of lipopolysaccharide across the periplasm in E. coli. Science 338(6111):1214-17
97. Osman C, Haag M, Wieland FT, Brügger B, Langer T. 2010. A mitochondrial phosphatase required for cardiolipin biosynthesis: the PGP phosphatase Gep4. EMBO J. 29(12):1976-87
98. Peng D, Hong W, Choudhury BP, Carlson RW, Gu X-X. 2005. Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate. Infect. Immun. 73(11):7569-77
99. Phillips NJ, Adin DM, Stabb EV, McFall-Ngai MJ, Apicella MA, Gibson BW. 2011. The lipid A from Vibrio fischeri lipopolysaccharide: a unique structure bearing a phosphoglycerol moiety. J. Biol. Chem. 286(24):21203-19
100. PrideAC, Guan Z, TrentMS. 2014. Characterization of the Vibrio cholerae VolA surface-exposed lipoprotein lysophospholipase. J. Bacteriol. 196(8):1619-26
101. Pring BG, JanssonAM, PerssonK,Andersson I,Gagner-Milchert I, et al. 1989. Synthesis of 8-substituted derivatives of the 2-deoxy analogue of 3-deoxy-β-D-manno-2-octulopyranosonic acid (2-deoxy-beta-KDO) as inhibitors of 3-deoxy-D-manno-octulosonate cytidylyltransferase. J. Med. Chem. 32(5):1069-74
102. Qureshi N, Takayama K, Ribi E. 1982. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257(19):11808-15
103. Raetz CR. 1986. Molecular genetics of membrane phospholipid synthesis. Annu. Rev. Genet. 20:253-95
104. Raetz CR, Roderick SL. 1995. A left-handed parallel β helix in the structure of UDP-Nacetylglucosamine acyltransferase. Science 270(5238):997-1000
105. Raetz CRH, Reynolds CM, Trent MS, Bishop RE. 2007. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76(1):295-329
106. Raetz CRH, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700
107. Reyes CL, Chang G. 2005. Structure of the ABC transporterMsbA in complex with ADP•vanadate and lipopolysaccharide. Science 308(5724):1028-31
108. Roier S, Blume T, Klug L, Wagner GE, Elhenawy W, et al. 2015. A basis for vaccine development: comparative characterization of Haemophilus influenzae outer membrane vesicles. Int. J. Med. Microbiol. 305(3):298-309
109. Rubin EJ, O'Brien JP, Ivanov PL, Brodbelt JS, Trent MS. 2014. Identification of a broad family of lipid A late acyltransferases with non-canonical substrate specificity. Mol. Microbiol. 91(5):887-99
110. Ruiz N, Gronenberg LS, Kahne D, Silhavy TJ. 2008. Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli. PNAS 105(14):5537-42
111. Salkowski CA, Detore GR, Vogel SN. 1997. Lipopolysaccharide and monophosphoryl lipid A differentially regulate interleukin-12, gamma interferon, and interleukin-10 mRNA production in murine macrophages. Infect. Immun. 65(8):3239-47
112. Schroeder J, Aebischer T. 2009. Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses. Vaccine 27(48):6748-54
113. Schwechheimer C, KuehnMJ. 2015. Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions. Nat. Rev. Microbiol. 13(10):605-19
114. Sherman DJ, Okuda S, Denny WA, Kahne D. 2013. Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli. Bioorg. Med. Chem. 21(16):4846-51
115. Silipo A, Vitiello G, Gully D, Sturiale L, Chaintreuil C, et al. 2014. Covalently linked hopanoid-lipid A improves outer-membrane resistance of a Bradyrhizobium symbiont of legumes. Nat. Commun. 5:5106
116. Smith WP, Tai PC, Davis BD. 1981. Bacillus licheniformis penicillinase: cleavages and attachment of lipid during cotranslational secretion. PNAS 78(6):3501-5
117. Snijder HJ, Dijkstra BW. 2000. Bacterial phospholipase A: Structure and function of an integral membrane phospholipase. Biochim. Biophys. Acta 1488(1-2):91-101
118. Sohlenkamp C, Geiger O. 2016. Bacterial membrane lipids: diversity in structures and pathways. FEMS Microbiol. Rev. 40(1):133-59
119. Sperandeo P, Cescutti R, Villa R, Benedetto CD, Candia D, et al. 2007. Characterization of LptA and LptB, two essential genes implicated in lipopolysaccharide transport to the outer membrane of Escherichia coli. J. Bacteriol. 189(1):244-53
120. Sperandeo P, Lau FK, Carpentieri A, Castro CD, Molinaro A, et al. 2008. Functional analysis of the protein machinery required for transport of lipopolysaccharide to the outer membrane of Escherichia coli. J. Bacteriol. 190(13):4460-69
121. Sperandeo P, Pozzi C, Deho G, Polissi A. 2006. Non-essential KDO biosynthesis and new essential cell envelope biogenesis genes in the Escherichia coli yrbG-yhbG locus. Res. Microbiol. 157(6):547-58
122. Srinivas N, Jetter P, Ueberbacher BJ, Werneburg M, Zerbe K, et al. 2010. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327(5968):1010-13
123. Steeghs L, den Hartog R, den Boer A, Zomer B, Roholl P, van der Ley P. 1998. Meningitis bacterium is viable without endotoxin. Nature 392(6675):449-50
124. Sutterlin HA, Shi H, May KL, Miguel A, Khare S, et al. 2016. Disruption of lipid homeostasis in the gram-negative cell envelope activates a novel cell death pathway. PNAS 113:E1565-74
125. Tamura Y, Harada Y, Nishikawa S, Yamano K, Kamiya M, et al. 2013. Tam41 is a CDP-diacylglycerol synthase required for cardiolipin biosynthesis in mitochondria. Cell Metab. 17(5):709-18
126. Tan BK, Bogdanov M, Zhao J, Dowhan W, Raetz CRH, Guan Z. 2012. Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and phosphatidylglycerol as substrates.PNAS109(41):16504-9
127. Tani C, Stella M, Donnarumma D, Biagini M, Parente P, et al. 2014. Quantification by LC-MSE of outer membrane vesicle proteins of the Bexsero R- vaccine. Vaccine 32(11):1273-79
128. Tefsen B, Bos MP, Beckers F, Tommassen J, de Cock H. 2005. MsbA is not required for phospholipid transport in Neisseria meningitidis. J. Biol. Chem. 280(43):35961-66
129. Thompson BS, Chilton PM,Ward JR, Evans JT, Mitchell TC. 2005. The low-toxicity versions of LPS, MPLR- adjuvant and RC529, are efficient adjuvants for CD4+ T cells. J. Leukoc. Biol. 78(6):1273-80
130. Tokunaga M, Tokunaga H, Wu HC. 1982. Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. PNAS 79(7):2255-59
131. Tomaras AP, McPherson CJ, Kuhn M, Carifa A,Mullins L, et al. 2014. LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in gram-negative pathogens. mBio 5(5):e01551-14
132. Tran AX,Dong C,Whitfield C. 2010. Structure and functional analysis of LptC, a conserved membrane protein involved in the lipopolysaccharide export pathway in Escherichia coli. J. Biol. Chem. 285(43):33529-39
133. TrentMS, SteadCM, Tran AX,Hankins JV. 2006. Diversity of endotoxin and its impact on pathogenesis. J. Endotoxin Res. 12(4):205-23
134. UrferM, Bogdanovic J, LoMonte F, Moehle K, ZerbeK, et al. 2016. A peptidomimetic antibiotic targets outer membrane proteins and disrupts selectively the outer membrane in Escherichia coli. J. Biol. Chem. 291(4):1921-32
135. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. 2008. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. PNAS 105(52):20858-63
136. Vamadevan AS, Fukata M, Arnold ET, Thomas LS, Hsu D, Abreu MT. 2010. Regulation of TLR4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. Innate Immun. 16(2):93-103
137. van de Waterbeemd B, Streefland M, van der Ley P, Zomer B, van Dijken H, et al. 2010. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine 28(30):4810-16
138. van der Ley P, van den Dobbelsteen G. 2011. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants. Hum. Vaccin. 7(8):886-90
139. Vorachek-Warren MK, Ramirez S, Cotter RJ, Raetz CRH. 2002. A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A. J. Biol. Chem. 277(16):14194-205
140. Vozza N, Feldman M. 2015. Glyco-engineering O-antigen-based vaccines and diagnostics in E. coli. In Glyco-Engineering, ed A Castilho, pp. 57-70. New York: Springer
141. Wai SN, Lindmark B, Söderblom T, Takade A, Westermark M, et al. 2003. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell. 115(1):25-35
142. Wang X, Bogdanov M, Dowhan W. 2002. Topology of polytopic membrane protein subdomains is dictated by membrane phospholipid composition. EMBO J. 21(21):5673-81
143. Werneburg M, Zerbe K, Juhas M, Bigler L, Stalder U, et al. 2012. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics. Chembiochem Eur. J. Chem. Biol. 13(12):1767-75
144. White KA, Lin S, Cotter RJ, Raetz CR. 1999. A Haemophilus influenzae gene that encodes a membrane bound 3-deoxy-D-manno-octulosonic acid (Kdo) kinase: possible involvement of Kdo phosphorylation in bacterial virulence. J. Biol. Chem. 274(44):31391-400
145. Whitfield C, Trent MS. 2014. Biosynthesis and export of bacterial lipopolysaccharides. Annu. Rev. Biochem. 83(1):99-128
146. Woebking B, Reuter G, Shilling RA, Velamakanni S, Shahi S, et al. 2005. Drug-lipid A interactions on the Escherichia coli ABC transporter Msb. J. Bacteriol. 187(18):6363-69
147. Wu HC, Lai JS, Hayashi S, Giam CZ. 1982. Biogenesis of membrane lipoproteins in Escherichia coli. Biophys. J. 37(1):307-15
148. XiaW, DowhanW. 1995. In vivo evidence for the involvement of anionic phospholipids in initiation of DNA replication in Escherichia coli. PNAS 92(3):783-87
149. Xu X, Wang J, Grison C, Petek S, Coutrot P, et al. 2003. Structure-based design of novel inhibitors of 3-deoxy-D-manno-octulosonate 8-phosphate synthase. Drug Des. Discov. 18(2-3):91-99
150. Yakushi T, Masuda K, Narita S, Matsuyama S, Tokuda H. 2000. A new ABC transporter mediating the detachment of lipid-modified proteins from membranes. Nat. Cell Biol. 2(4):212-18
151. Young HE, Zhao J, Barker JR, Guan Z, Valdivia RH, Zhou P. 2016. Discovery of the elusive UDPdiacylglucosamine hydrolase in the lipid A biosynthetic pathway in Chlamydia trachomatis. mBio 7:e00090-16
152. Zhang J,Guan Z,Murphy AN, Wiley SE, Perkins GA, et al. 2011. Mitochondrial phosphatase PTPMT1 is essential for cardiolipin biosynthesis. Cell Metab. 13(6):690-700
153. Zhang W, Campbell HA, King SC, Dowhan W. 2005. Phospholipids as determinants of membrane protein topology: Phosphatidylethanolamine is required for the proper topological organization of the gamma-aminobutyric acid permease (GabP) of Escherichia coli. J. Biol. Chem. 280(28):26032-38